BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 24, 2019
View Archived Issues
One and done synthesize and screen IDs aggregation inhibitors
Read More
Cerevel initiates phase Ib trial of CVL-231 in schizophrenia
Read More
Pilot trial shows efficacy of intratumoral plasmid IL-12 delivery in Merkel cell carcinoma
Read More
Ex vivo gene-corrected autologous cell therapy for chronic RDEB wounds: results of phase I/IIa trial
Read More
First phase II data for antolimab in eosinophilic gastritis/gastroenteritis presented
Read More
Muscarinic M1 receptor antagonist PIPE-359 shows promising in vivo results for the treatment of MS
Read More
Second interim OS analysis from phase III study of margetuximab in HER2-positive breast cancer
Read More
New variant in CCHCR1 gene found associated with alopecia areata
Read More
PhagoMed announces discovery of novel candidate for the treatment of bacterial vaginosis
Read More
Second ferroptosis mechanism is tumor cell liability
Read More
Biomica, Weizmann Institute of Science to develop treatment for antibiotic-resistant bacteria
Read More
Arecor announces a joint research, development and commercialization agreement with JDRF
Read More
PTC Therapeutics patents compounds for Huntington's disease
Read More
Arvinas presents initial data for its PROTAC targeted protein degraders
Read More
Emory University discloses ionotropic glutamate GluN2C/D receptor antagonists
Read More
Neuropore Therapies identifies TLR2 antagonists
Read More
Agios Pharmaceuticals synthesizes new MAT2A inhibitors
Read More
Enanta Pharmaceuticals describes new HBV antivirals
Read More
Microbio constructs aptamer targeting LAG-3 for cancer immunotherapy
Read More
Rapt Therapeutics studies oral CCR4 antagonist RPT-193 in first-in-human trial
Read More
NIH grant supports Vironika's work on small-molecule inhibitors to eradicate HSV latent infection
Read More
FDA clears BlueWillow's IND for anthrax vaccine candidate BW-1010
Read More
New phase II trial studies suvorexant for comorbid sleep disorder and alcohol dependence
Read More
LIDDS reports data from OLE study of Liproca depot in prostate cancer
Read More
FDA approves Zejula and companion diagnostic for late-line ovarian cancer
Read More